Beihua Kong

Shandong University — China

Medicine · Health Sciences

37h-index4.3kcitations192works3.92yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(64), Endometrial and Cervical Cancer Treatments(40), MicroRNA in disease regulation(24), Endometriosis Research and Treatment(18), BRCA gene mutations in cancer(17)

Publications192 total

Chinese expert consensus on the hematoporphyrin derivative (HpD) photodynamic therapy in cervical high-grade squamous intraepithelial lesion (2025)
Gynecology and Obstetrics Clinical Medicine·2025Open Access
Sentinel-Lymph-Node Biopsy Alone or with Lymphadenectomy in Cervical Cancer
New England Journal of Medicine·2025· 9 cited
1090P Final overall survival (OS) analysis of L-MOCA: Olaparib maintenance monotherapy in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSR OC)
Annals of Oncology·2025
Efbemalenograstim alfa for primary prophylaxis of chemotherapy-induced neutropenia in patients with ovarian and cervical cancer: A single-arm, multicenter clinical trial
Gynecologic Oncology·2025
Association of aspirin and ibuprofen use with endometrial cancer risk in the <scp>PLCO</scp> dataset
International Journal of Cancer·2025· 1 cited
Sentinel lymph node biopsy versus pelvic lymphadenectomy in cervical cancer: The PHENIX trial.
Journal of Clinical Oncology·2025· 6 cited
Efbemalenograstim alfa for primary prophylaxis of chemotherapy-induced neutropenia in patients with ovarian and cervical cancer: A single-arm, multicenter clinical trial.
Journal of Clinical Oncology·2025
Real-world characteristics and treatment patterns in Chinese patients with newly diagnosed endometrial cancer
Chinese Medical Journal·2025· 1 citedOpen Access
Role of KLF5 in enhancing ovarian cancer stemness and PARPi resistance: mechanisms and therapeutic targeting
Journal of Translational Medicine·2025· 1 citedOpen Access
PRMT5-mediated methylation of METTL3 promotes cisplatin resistance in ovarian cancer by facilitating DNA repair mechanisms
Cell Reports·2025· 11 citedOpen Access
Mirvetuximab soravtansine: current and future applications
Journal of Hematology & Oncology·2025· 6 citedOpen Access
Enhanced Wildfire Detection Using a Mixture of Experts Approach
Journal of Student Research·2025Open Access
Targeting platinum-resistant ovarian cancer by disrupting histone and RAD51 lactylation
Theranostics·2025· 28 citedOpen Access
A Study on Value Perception in Selecting Financial Institution: Targeting Young People in Their 20s
The Korean Academic Association of Business Administration·2025
Evaluation of the prognostic value of lymphadenectomy in low-grade serous ovarian cancer: A case-control multicenter retrospective study
2024Open Access
Siamese deep learning video flow cytometry for automatic and label-free clinical cervical cancer cell analysis
Biomedical Optics Express·2024· 4 citedOpen Access
UBE2T-mediated stemness enhancement: unraveling platinum resistance mechanisms in ovarian cancer
2024Open Access
TP004/#1496  Sentinel lymph node biopsy versus pelvic lymphadenectomy in early- stage cervical cancer: a multi-center randomized trial
2023Open Access
PO012LBA/#1511  Flames: randomized phase 3 trial of maintenance senaparib in patients with newly diagnosed advanced ovarian cancer
2023Open Access
Prognostic significance of positive peritoneal cytology in endometrial carcinoma based on ESGO/ESTRO/ESP risk classification: A multicenter retrospective study
Gynecologic Oncology·2023· 12 cited
page 1 of 10Next →

Frequent Co-authors

Wenxin Zheng(8), Xingsheng Yang(8), Ruifen Dong(7), Lin Jia(6), Qifeng Yang(6), Chunping Qiu(6), Xun Qu(6), Jie Jiang(6), Cunzhong Yuan(6), Kun Song(6), Zhaojian Liu(5), Baoxia Cui(5), Oluwole Fadare(4), Margaux J. Kanis(4), Yun Zhang(4), Chengjuan Jin(4), Yan Shi(4), Xiang Li(3), Hualei Bu(3), Chenggong Sun(3)